Oct-3/4 modulates the drug-resistant phenotype of glioblastoma cells through expression of ATP binding cassette transporter G2 - Hosokawa, Yuki; Takahashi, Hisaaki; Inoue, Akihiro; Kawabe, Yuya; Funahashi, Yu; Kameda, Kenji; Sugimoto, Kana; Yano, Hajime; Harada, Hironobu; Kohno, Shohei; Ohue, Shiro; Ohnishi, Takanori; et al. (Biochimica et biophysica acta, 2015)
Keywords: ABC transporter; ABC transporters; Animals; Antimetabolites, Antineoplastic - metabolism; Antimetabolites, Antineoplastic - pharmacology; antineoplastic agents; ATP Binding Cassette Transporter, Sub-Family G, Member 2; ATP-Binding Cassette Transporters - metabolism; Cell Line, Tumor; Cell Survival - drug effects; Dose-Response Relationship, Drug; Doxorubicin - metabolism; Doxorubicin - pharmacology; Drug resistance; Drug Resistance, Neoplasm - genetics; drug therapy; excretion; genes; Glioblastoma; Glioblastoma - drug therapy; Glioblastoma - genetics; Glioblastoma - metabolism; Glioblastoma - pathology; Humans; L-Lactate Dehydrogenase - metabolism; lactate dehydrogenase; Male; Mice, Inbred BALB C; Mice, Nude; NAD ADP-ribosyltransferase; Neoplasm Proteins - metabolism; neoplasms; Oct-3/4; Octamer Transcription Factor-3 - genetics; Octamer Transcription Factor-3 - metabolism; patients; Phenotype; Poly(ADP-ribose) Polymerases - metabolism; prognosis; quantitative polymerase chain reaction; RNA Interference; Signal Transduction; stem cells; Time Factors; Transfection; Tumor Burden - drug effects; PBS; ABC; HIF; Glioblastoma; PARP; EGFP; Doxy; Drug resistance; DMEM; LDH; PI3K; FBS; Oct-3/4; qPCR; MDR; GB; AID; HE; ABC transporter